Skip to main content
. 2023 Dec 15;19(10):2290–2298. doi: 10.4103/1673-5374.390958

Figure 3.

Figure 3

LbGP enhances the retinal light responses of photoreceptor-degenerative mice.

(A) Representative electroretinogram traces of each group to flashes at Scotopic 3.0 cd∙s/m2. (B) Proportions of mice with (Con, n = 8; MNU, n = 8; LbGP, n = 10) and without (Con, n = 0; MNU, n = 3; LbGP, n = 2) responsiveness to light in each group. (C) Peak amplitudes of the a- and b-waves under scotopic conditions for each flash intensity (Con, n = 8; MNU, n = 8; LbGP, n = 10). (D) Latency of the a- and b-waves, showing increased retinal light responses under LbGP treatment (Con, n = 8; MNU, n = 8; LbGP, n = 10). Data are expressed as mean ± standard error of the mean; *P < 0.05, **P < 0.01, ***P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). Con: C57BL/6J mice; LbGP: N-methyl-N-nitrosourea-injured mice with Lycium barbarum glycopeptide treatment; MNU: N-methyl-N-nitrosourea-injured mice without treatment.